Zuranolone

Molecular mass: 409.574 g/mol  PubChem compound: 86294073

Therapeutic indications

Zuranolone is indicated for:

Postpartum depression

Population group: women, only adults (18 - 65 years old)

Postpartum depression

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Zuranolone is contraindicated in the following cases:

Effects on ability to drive and use machines

Effects on ability to drive and use machines

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

Structured Product Labeling (SPL/PLR) 2023: ZURZUVAE Capsule
< Previous: Overview
Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈